TRICLOSAN

TRICLOSAN was reported 577 times

TRICLOSAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 84 0.1257
1 SERONEGATIVE ARTHRITIS 141 0.1230
2 LUPUS VULGARIS 137 0.1087
3 RETINITIS 133 0.0769
4 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 120 0.0579
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 115 0.0574
6 SPINAL FUSION FRACTURE 1 0.0556
7 DISLOCATION OF VERTEBRA 118 0.0517
8 SWOLLEN JOINT COUNT INCREASED 130 0.0407
9 RHEUMATIC FEVER 131 0.0294
10 BONE EROSION 95 0.0268
11 RHEUMATOID FACTOR POSITIVE 133 0.0230
12 SWOLLEN JOINT COUNT 5 0.0200
13 WOUND INFECTION 215 0.0196
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 11 0.0196
15 JOINT DISLOCATION 203 0.0192
16 HYPERCHOLESTEROLAEMIA 168 0.0174
17 SPONDYLITIS 63 0.0173
18 HYPOCHOLESTEROLAEMIA 6 0.0170
19 WALKING AID USER 112 0.0170
20 MUSCLE INJURY 140 0.0169
21 JOINT RANGE OF MOTION DECREASED 204 0.0152
22 SPINAL FUSION SURGERY 61 0.0150
23 LOW DENSITY LIPOPROTEIN 1 0.0147
24 LUPUS-LIKE SYNDROME 133 0.0147
25 DUODENAL ULCER PERFORATION 108 0.0145
26 PEMPHIGUS 180 0.0144
27 ACQUIRED PORPHYRIA 1 0.0141
28 HELICOBACTER INFECTION 143 0.0139
29 BREAST CANCER STAGE III 88 0.0136
30 GRIP STRENGTH DECREASED 116 0.0132
31 GRIP STRENGTH 3 0.0131
32 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 91 0.0127
33 TENDER JOINT COUNT 1 0.0119
34 RED BLOOD CELL SEDIMENTATION RATE INCREASED 127 0.0115
35 FOLLICULITIS 116 0.0111
36 EXOSTOSIS 100 0.0109
37 PERICARDITIS 182 0.0108
38 C-REACTIVE PROTEIN 10 0.0108
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 69 0.0106
40 ANTIPHOSPHOLIPID ANTIBODIES 2 0.0103
41 AUTOIMMUNE DISORDER 100 0.0102
42 SCIATICA 161 0.0101
43 PRESCRIBED UNDERDOSE 201 0.0101
44 IRRITABLE BOWEL SYNDROME 210 0.0098
45 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 1 0.0095
46 FOOT DEFORMITY 104 0.0094
47 HIP ARTHROPLASTY 141 0.0092
48 HAND DEFORMITY 119 0.0091
49 GLUTAMATE DEHYDROGENASE INCREASED 1 0.0090
50 X-RAY ABNORMAL 15 0.0084
51 PORPHYRIA ACUTE 12 0.0084
52 SYNOVITIS 148 0.0082
53 JOINT STIFFNESS 205 0.0078
54 PRESCRIBED OVERDOSE 151 0.0078
55 WOUND 211 0.0075
56 DRUG TOLERANCE DECREASED 21 0.0075
57 OVERLAP SYNDROME 5 0.0071
58 PULMONARY FIBROSIS 137 0.0071
59 TYPE 2 DIABETES MELLITUS 235 0.0070
60 LOWER LIMB FRACTURE 132 0.0069
61 FACET JOINT SYNDROME 22 0.0068
62 HEPATIC ENZYME 1 0.0067
63 FIBROMYALGIA 155 0.0064
64 LIVER FUNCTION TEST INCREASED 134 0.0062
65 LIVER INJURY 152 0.0062
66 VARICELLA VIRUS TEST POSITIVE 1 0.0059
67 HEPATIC CIRRHOSIS 108 0.0057
68 KNEE ARTHROPLASTY 121 0.0057
69 PERIPHERAL VENOUS DISEASE 23 0.0056
70 GLOSSODYNIA 122 0.0054
71 IMPAIRED HEALING 171 0.0052
72 OSTEOARTHRITIS 199 0.0047
73 SYSTEMIC LUPUS ERYTHEMATOSUS 158 0.0044
74 UPPER RESPIRATORY TRACT INFECTION 200 0.0043
75 DISABILITY 84 0.0042
76 PSORIATIC ARTHROPATHY 161 0.0040
77 TRI-IODOTHYRONINE FREE DECREASED 1 0.0039
78 OSTEOPOROSIS 161 0.0039
79 JOINT DESTRUCTION 6 0.0039
80 ROAD TRAFFIC ACCIDENT 157 0.0037
81 EAR INFECTION 97 0.0036
82 INSPIRATORY CAPACITY DECREASED 1 0.0036
83 GAIT INABILITY 120 0.0036
84 ONYCHOMADESIS 15 0.0036
85 DAIRY INTOLERANCE 1 0.0036
86 LIP DRY 32 0.0035
87 WHEEZING 207 0.0035
88 DELIRIUM 119 0.0034
89 C-REACTIVE PROTEIN INCREASED 120 0.0033
90 DRUG-INDUCED LIVER INJURY 102 0.0032
91 OEDEMA 174 0.0032
92 BLEPHAROSPASM 20 0.0032
93 UTERINE NEOPLASM 1 0.0030
94 INFUSION RELATED REACTION 196 0.0030
95 POLYMERASE CHAIN REACTION POSITIVE 1 0.0029
96 C-REACTIVE PROTEIN ABNORMAL 18 0.0028
97 ANKLE ARTHROPLASTY 1 0.0028
98 BLOOD CHOLESTEROL INCREASED 128 0.0027
99 INFUSION SITE REACTION 8 0.0027
100 TOXIC EPIDERMAL NECROLYSIS 40 0.0026
101 MOBILITY DECREASED 183 0.0025
102 LIVE BIRTH 20 0.0024
103 INJURY 167 0.0024
104 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 40 0.0024
105 ONYCHOMYCOSIS 10 0.0023
106 BURSITIS 26 0.0021
107 NAIL DISORDER 18 0.0021
108 PUSTULAR PSORIASIS 7 0.0020
109 ARTHROPATHY 110 0.0020
110 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 94 0.0020
111 BREAST CANCER STAGE I 18 0.0019
112 HEPATIC ENZYME INCREASED 132 0.0019
113 STOMATITIS 115 0.0019
114 BREAST CANCER STAGE II 15 0.0018
115 MUSCULOSKELETAL STIFFNESS 156 0.0018
116 THYROXINE FREE DECREASED 1 0.0018
117 BLISTER 98 0.0017
118 AMNESIA 111 0.0017
119 VISUAL IMPAIRMENT 201 0.0016
120 DERMATOSIS 1 0.0016
121 DISCOMFORT 97 0.0016
122 SINUSITIS 162 0.0016
123 SUSPECTED OFF LABEL USE 7 0.0015
124 ULCER HAEMORRHAGE 10 0.0015
125 TACHYCARDIA 129 0.0015
126 MYOSITIS 13 0.0014
127 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
128 RHEUMATOID ARTHRITIS 154 0.0014
129 URTICARIA 224 0.0013
130 HYPOAESTHESIA 200 0.0013
131 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
132 MUSCULAR WEAKNESS 150 0.0013
133 OEDEMA PERIPHERAL 158 0.0013
134 SWELLING 120 0.0013
135 BRONCHITIS 94 0.0013
136 GENERAL PHYSICAL HEALTH DETERIORATION 145 0.0013
137 CONTUSION 120 0.0012
138 RASH VESICULAR 6 0.0012
139 INFECTION 178 0.0012
140 DYSBIOSIS 1 0.0012
141 LEUKOCYTURIA 1 0.0012
142 ARTHRITIS 95 0.0012
143 PRODUCT LABEL CONFUSION 7 0.0012
144 BACK INJURY 13 0.0012
145 JOINT SWELLING 141 0.0012
146 PERIPHERAL SWELLING 172 0.0011
147 SLEEP DISORDER 77 0.0011
148 WEIGHT INCREASED 241 0.0011
149 GENERAL SYMPTOM 8 0.0011
150 OBESITY 17 0.0011
151 DYSPEPSIA 103 0.0010
152 RED BLOOD CELLS URINE POSITIVE 1 0.0010
153 ASTHMA 116 0.0010
154 NIGHT SWEATS 33 0.0010
155 MEMORY IMPAIRMENT 139 0.0010
156 PSORIASIS 132 0.0010
157 NASOPHARYNGITIS 186 0.0010
158 HYPERTENSION 213 0.0010
159 HYPERSENSITIVITY 184 0.0010
160 EYE INJURY 3 0.0010
161 HYPOCHROMIC ANAEMIA 1 0.0010
162 BONE MARROW OEDEMA 1 0.0010
163 POLYARTHRITIS 5 0.0009
164 TOXOPLASMOSIS 1 0.0009
165 COELIAC DISEASE 9 0.0009
166 PREGNANCY AFTER POST COITAL CONTRACEPTION 2 0.0009
167 ABDOMINAL DISCOMFORT 147 0.0009
168 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
169 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
170 FOLATE DEFICIENCY 1 0.0009
171 BONE MARROW TOXICITY 1 0.0008
172 TASTE DISORDER 17 0.0008
173 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
174 XEROSIS 1 0.0008
175 DRUG TOLERANCE 4 0.0008
176 GLUCOSE URINE PRESENT 1 0.0008
177 HEPATOSPLENOMEGALY 2 0.0008
178 EAR PAIN 15 0.0008
179 DRUG INTOLERANCE 74 0.0008
180 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
181 PROTEIN TOTAL INCREASED 2 0.0008
182 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
183 HYPERTRANSAMINASAEMIA 5 0.0007
184 ALOPECIA 141 0.0007
185 RENAL TUBULAR DISORDER 2 0.0007
186 WEIGHT DECREASED 198 0.0007
187 FEBRILE BONE MARROW APLASIA 3 0.0007
188 POST HERPETIC NEURALGIA 1 0.0007
189 THERAPEUTIC PRODUCT EFFECT DECREASED 30 0.0007
190 MYELOFIBROSIS 2 0.0007
191 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
192 LUNG DISORDER 32 0.0007
193 MEAN CELL VOLUME DECREASED 1 0.0006
194 CONFUSIONAL STATE 102 0.0006
195 CHEST PAIN 116 0.0006
196 EPILEPSY 19 0.0006
197 FINGER DEFORMITY 3 0.0006
198 GAIT DISTURBANCE 117 0.0006
199 SPINAL CORD DISORDER 1 0.0006
200 IMMUNODEFICIENCY 9 0.0006
201 PAIN IN EXTREMITY 173 0.0006
202 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
203 DECREASED APPETITE 133 0.0006
204 TYPE I HYPERSENSITIVITY 2 0.0006
205 JOINT ARTHROPLASTY 1 0.0006
206 UTERINE POLYP 1 0.0006
207 OPHTHALMIC HERPES ZOSTER 1 0.0006
208 BACK DISORDER 9 0.0006
209 MATERNAL EXPOSURE DURING PREGNANCY 49 0.0005
210 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
211 ADVERSE EVENT 50 0.0005
212 AUTOIMMUNE THYROIDITIS 2 0.0005
213 SPINAL DISORDER 5 0.0005
214 PNEUMONIA 168 0.0005
215 DEVICE RELATED SEPSIS 1 0.0005
216 ADRENAL INSUFFICIENCY 6 0.0005
217 PYREXIA 170 0.0005
218 ADVERSE DRUG REACTION 43 0.0005
219 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
220 VOMITING 222 0.0005
221 RENAL NEOPLASM 1 0.0005
222 CONDITION AGGRAVATED 143 0.0005
223 INFLAMMATION 24 0.0005
224 DEPRESSION 105 0.0005
225 RENAL TUBULAR ACIDOSIS 1 0.0005
226 TREATMENT FAILURE 37 0.0004
227 CHRONIC GASTRITIS 1 0.0004
228 PRURITUS 169 0.0004
229 EYELID DISORDER 1 0.0004
230 UROSEPSIS 4 0.0004
231 MUSCULOSKELETAL PAIN 22 0.0004
232 ILL-DEFINED DISORDER 25 0.0004
233 LIVER DISORDER 18 0.0004
234 DENTAL OPERATION 1 0.0004
235 RESPIRATORY DISORDER 12 0.0004
236 DERMATITIS EXFOLIATIVE 2 0.0004
237 PREGNANCY 8 0.0004
238 THERAPY NON-RESPONDER 17 0.0004
239 FREQUENT BOWEL MOVEMENTS 10 0.0004
240 NORMAL NEWBORN 2 0.0004
241 RASH 158 0.0004
242 ANXIETY 102 0.0004
243 GRANULOCYTOPENIA 2 0.0004
244 MIGRAINE 32 0.0003
245 HEPATITIS CHOLESTATIC 2 0.0003
246 UNDERDOSE 24 0.0003
247 MUSCLE SPASTICITY 4 0.0003
248 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
249 ARTHRALGIA 124 0.0003
250 CLOSTRIDIAL INFECTION 1 0.0003
251 COLITIS ULCERATIVE 13 0.0003
252 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
253 WEIGHT FLUCTUATION 3 0.0003
254 DRY MOUTH 23 0.0003
255 PAIN 174 0.0003
256 DIZZINESS 139 0.0003
257 HEPATITIS 7 0.0003
258 EXPOSURE DURING PREGNANCY 17 0.0003
259 CARDIAC DYSFUNCTION 1 0.0003
260 PNEUMONIA FUNGAL 1 0.0003
261 MEDICATION ERROR 14 0.0003
262 VITAMIN B12 DEFICIENCY 1 0.0002
263 PARAESTHESIA 38 0.0002
264 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
265 MUSCLE FATIGUE 1 0.0002
266 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
267 TONGUE DISCOMFORT 1 0.0002
268 PULMONARY TUBERCULOSIS 1 0.0002
269 NECK PAIN 13 0.0002
270 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
271 NODULE 3 0.0002
272 TONGUE DISCOLOURATION 1 0.0002
273 PULMONARY FUNCTION TEST DECREASED 1 0.0002
274 PANCREATITIS 12 0.0002
275 WHEELCHAIR USER 1 0.0002
276 NAUSEA 177 0.0002
277 GASTROINTESTINAL DISORDER 20 0.0002
278 HEADACHE 139 0.0002
279 HAEMOGLOBIN INCREASED 1 0.0002
280 HYPOKALAEMIA 10 0.0002
281 INSOMNIA 57 0.0002
282 SQUAMOUS CELL CARCINOMA 2 0.0002
283 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
284 INFLAMMATORY BOWEL DISEASE 2 0.0002
285 STAPHYLOCOCCAL SEPSIS 1 0.0002
286 FOOT OPERATION 1 0.0002
287 PROTEIN URINE PRESENT 1 0.0002
288 HEPATIC ENZYME ABNORMAL 1 0.0002
289 KLEBSIELLA INFECTION 1 0.0002
290 FLUID RETENTION 10 0.0002
291 BODY TEMPERATURE INCREASED 4 0.0002
292 FEELING HOT 12 0.0002
293 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
294 APLASTIC ANAEMIA 1 0.0002
295 ERYTHEMA OF EYELID 1 0.0002
296 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
297 DYSPNOEA 104 0.0002
298 FATIGUE 140 0.0002
299 RASH MACULO-PAPULAR 4 0.0002
300 PRODUCT USE ISSUE 33 0.0002
301 DIARRHOEA 112 0.0002
302 LABORATORY TEST ABNORMAL 5 0.0002
303 GASTROENTERITIS VIRAL 3 0.0002
304 THERAPEUTIC RESPONSE DECREASED 10 0.0002
305 RECTAL HAEMORRHAGE 7 0.0002
306 OFF LABEL USE 142 0.0002
307 HYPOCALCAEMIA 3 0.0002
308 MUSCLE SPASMS 29 0.0002
309 ENTERITIS 1 0.0002
310 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
311 PRODUCT FORMULATION ISSUE 1 0.0002
312 ADVERSE REACTION 2 0.0002
313 CARDIAC FAILURE ACUTE 1 0.0001
314 POSTOPERATIVE WOUND INFECTION 1 0.0001
315 CROHN'S DISEASE 1 0.0001
316 HAEMOPTYSIS 4 0.0001
317 LEUKOPENIA 7 0.0001
318 GASTROENTERITIS 2 0.0001
319 PEMPHIGOID 1 0.0001
320 HEPATOCELLULAR CARCINOMA 1 0.0001
321 DIABETES MELLITUS 10 0.0001
322 ABDOMINAL PAIN UPPER 27 0.0001
323 SHOCK 3 0.0001
324 ANKLE FRACTURE 2 0.0001
325 MENSTRUAL DISORDER 1 0.0001
326 SECOND PRIMARY MALIGNANCY 1 0.0001
327 SKIN LESION 3 0.0001
328 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
329 ABORTION INDUCED 1 0.0001
330 PROTEINURIA 2 0.0001
331 LETHARGY 6 0.0001
332 PRODUCT QUALITY ISSUE 14 0.0001
333 VAGINAL DISCHARGE 1 0.0001
334 EYELID PTOSIS 1 0.0001
335 LIMB DISCOMFORT 3 0.0001
336 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
337 RASH PRURITIC 5 0.0001
338 TREATMENT NONCOMPLIANCE 5 0.0001
339 ASPIRATION 1 0.0001
340 INJECTION SITE REACTION 6 0.0001
341 EYELID OEDEMA 1 0.0001
342 SPINAL PAIN 1 0.0001
343 LYMPHADENOPATHY 3 0.0001
344 MALAISE 36 0.0001
345 CYTOPENIA 1 0.0001
346 ABDOMINAL PAIN 19 0.0001
347 ENCEPHALOPATHY 2 0.0001
348 PLATELET COUNT INCREASED 1 0.0001
349 HAIR TEXTURE ABNORMAL 1 0.0001
350 PRODUCT TASTE ABNORMAL 1 0.0001
351 ANAPHYLACTIC REACTION 4 0.0001
352 THROMBOCYTOPENIA 8 0.0001
353 SKIN REACTION 1 0.0001
354 SINUS TACHYCARDIA 1 0.0001
355 PARAESTHESIA ORAL 1 0.0001
356 ASTHENIA 26 0.0001
357 SEPTIC SHOCK 3 0.0001
358 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
359 HYPOAESTHESIA ORAL 1 0.0001
360 BASAL CELL CARCINOMA 1 0.0001
361 LOSS OF CONSCIOUSNESS 8 0.0001
362 STAPHYLOCOCCAL INFECTION 2 0.0001
363 PHOTOSENSITIVITY REACTION 1 0.0001
364 NEOPLASM PROGRESSION 2 0.0001
365 HEAD DISCOMFORT 1 0.0001
366 TOOTHACHE 1 0.0001
367 BONE DISORDER 1 0.0001
368 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
369 DRUG INEFFECTIVE 72 0.0001
370 BLOOD GLUCOSE ABNORMAL 1 0.0001
371 PANCYTOPENIA 3 0.0001
372 PHOTOPHOBIA 1 0.0001
373 BLOOD SODIUM DECREASED 1 0.0001
374 POST PROCEDURAL COMPLICATION 1 0.0001
375 HAEMATOCRIT DECREASED 1 0.0001
376 PRODUCT PHYSICAL ISSUE 1 0.0000
377 PLEURAL EFFUSION 3 0.0000
378 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
379 IMPAIRED WORK ABILITY 1 0.0000
380 INTENTIONAL PRODUCT MISUSE 4 0.0000
381 HEPATOTOXICITY 1 0.0000
382 HEART RATE IRREGULAR 1 0.0000
383 PRODUCT PRESCRIBING ERROR 1 0.0000
384 NEURALGIA 1 0.0000
385 CARDIOVASCULAR DISORDER 1 0.0000
386 RESPIRATORY TRACT INFECTION 1 0.0000
387 ABDOMINAL DISTENSION 4 0.0000
388 SEDATION 1 0.0000
389 ANHEDONIA 1 0.0000
390 INJECTION SITE BRUISING 3 0.0000
391 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
392 URINARY INCONTINENCE 1 0.0000
393 HEPATIC FAILURE 1 0.0000
394 BONE DENSITY DECREASED 1 0.0000
395 DEATH 27 0.0000
396 HIP FRACTURE 1 0.0000
397 BLOOD CREATININE INCREASED 2 0.0000
398 LIP SWELLING 1 0.0000
399 EYE PRURITUS 1 0.0000
400 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
401 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
402 HAEMATURIA 1 0.0000
403 NIGHTMARE 1 0.0000
404 OVERDOSE 6 0.0000
405 ACCIDENTAL OVERDOSE 1 0.0000
406 DYSARTHRIA 1 0.0000
407 COLITIS 1 0.0000
408 EXTRA DOSE ADMINISTERED 1 0.0000
409 POLLAKIURIA 1 0.0000
410 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
411 SKIN IRRITATION 1 0.0000
412 NEPHROLITHIASIS 1 0.0000
413 HYPOTENSION 4 0.0000
414 BLOOD PRESSURE INCREASED 3 0.0000
415 HOSPITALISATION 3 0.0000
416 ECZEMA 1 0.0000
417 DEPRESSED MOOD 1 0.0000
418 FALL 6 0.0000
419 SEPSIS 2 0.0000
420 FLATULENCE 1 0.0000
421 HERPES ZOSTER 1 0.0000
422 BACK PAIN 4 0.0000
423 BONE PAIN 1 0.0000
424 SURGERY 1 0.0000
425 SUICIDE ATTEMPT 1 0.0000
426 HYPERHIDROSIS 2 0.0000
427 DEEP VEIN THROMBOSIS 1 0.0000
428 SWELLING FACE 1 0.0000
429 FEBRILE NEUTROPENIA 1 0.0000
430 INJECTION SITE PRURITUS 1 0.0000
431 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
432 EPISTAXIS 1 0.0000
433 ACUTE KIDNEY INJURY 2 0.0000
434 INJECTION SITE SWELLING 1 0.0000
435 INJECTION SITE HAEMORRHAGE 1 0.0000
436 DRUG DOSE OMISSION 2 0.0000
437 RENAL IMPAIRMENT 1 0.0000
438 MYALGIA 2 0.0000
439 NO ADVERSE EVENT 2 0.0000
440 SUICIDAL IDEATION 1 0.0000
441 BREAST CANCER 1 0.0000
442 HAEMOGLOBIN DECREASED 1 0.0000
443 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
444 CHILLS 1 0.0000
445 EMOTIONAL DISTRESS 1 0.0000
446 RENAL FAILURE 1 0.0000
447 NEUTROPENIA 1 0.0000
448 CEREBROVASCULAR ACCIDENT 1 0.0000
449 URINARY TRACT INFECTION 1 0.0000
450 MYOCARDIAL INFARCTION 1 0.0000
451 ANAEMIA 1 0.0000
452 ERYTHEMA 1 0.0000
453 FEELING ABNORMAL 1 0.0000